Helix Announces $50M Series C Funding To Continue Acceleration Into Clinical Population Genomics And Covid-19 Viral Surveillance
SAN MATEO, Calif., June 3, 2021 /PRNewswire/ -- Helix, the leading population genomics and COVID-19 testing company, has closed on its Series C funding round led by existing investors Warburg Pincus, DFJ Growth, Kleiner Perkins Caufield Byers, Mayo Clinic and Temasek. The $50M round will...
In this article
No tags related to this article.